Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
A team of experts recently developed the new system to differentiate between malignant and benign "second look" lesions on MRI for women with known breast cancer.
Since being approved by the U.S. Food and Drug Administration in 2011, DBT has become the most common method for breast cancer screening, and as of September 2022, 84% of all U.S. mammography screening facilities housed DBT units.
Experts recently questioned the necessity of scanning the axilla region during diagnostic breast ultrasound, as new data indicate that it is minimally beneficial for cancer detection.
A team of experts with the University of Maryland School of Medicine recently presented ChatGPT with a set of questions relative to breast cancer screening recommendations to determine whether the program could reliably offer appropriate guidance.
The FDA will soon require mammography providers to inform all patients of their breast density status. To anticipate how the update might affect key stakeholders, it’s important to understand exactly what has changed.
The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.
CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.
